Early onset inflammation in pre-insulin-resistant diet-induced obese rats does not affect the vasoreactivity of isolated small mesenteric arteries

Pharmacology

Volumn 90, Issue 3-4, 2012, Pages 125-132

  Blædel, Martin ^a,b   Raun, Kirsten ^a   Boonen, Harrie C M ^b   Sheykhzade, Majid ^b   Sams, Anette ^a  

^a HAGEDORN RESEARCH INSTITUTE   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Adiponectin; Diet induced obesity; Inflammation; Metabolic syndrome; Vascular dysfunction

Indexed keywords

ACETYLCHOLINE; ADIPONECTIN; CALCITONIN GENE RELATED PEPTIDE; ENDOTHELIN 1; GLUCOSE; INSULIN; INTERLEUKIN 1; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; NITROPRUSSIDE SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY DIAMETER; ARTICLE; BLOOD VESSEL REACTIVITY; BODY FAT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIETARY INTAKE; ENDOTHELIAL DYSFUNCTION; EXPERIMENTAL MODEL; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HYPERINSULINEMIA; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN TOLERANCE TEST; LIPID DIET; MALE; MESENTERIC ARTERY; METABOLIC PARAMETERS; MUSCLE ISOMETRIC CONTRACTION; MYOGRAPHY; NONHUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; VASCULAR DISEASE; WEIGHT GAIN;

ADIPOKINES; ANIMALS; CHEMOKINES; CYTOKINES; DIETARY FATS; INFLAMMATION; INSULIN RESISTANCE; MALE; MESENTERIC ARTERIES; OBESITY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84864096545     PISSN: 00317012     EISSN: 14230313     Source Type: Journal    
DOI: 10.1159/000340054     Document Type: Article

References (40)

1. Flegal KM, Carroll MD, Ogden CL, Curtin LR: Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010;303:235-241.
2. Hotamisligil GS: Inflammation and metabolic disorders. Nature 2006;444:860-867.
3. World Health Organization: WHO Media Center. Geneva, WHO, 2011.
4. Hotamisligil GS, Shargill NS, Spiegelman BM: Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993;259:87-91.
5. Ross R: Atherosclerosis-an inflammatory disease. N Engl J Med 1999;340:115-126.
6. Harrison DG, Guzik TJ, Lob HE, Madhur MS, Marvar PJ, Thabet SR, Vinh A, Weyand CM: Inflammation, immunity, and hypertension. Hypertension 2011;57:132-140.
7. Kahn R: Metabolic syndrome-what is the clinical usefulness? Lancet 2008;371: 1892-1893.
8. Dwinell MR: Online tools for understanding rat physiology. Brief Bioinform 2010;11: 431-439.
9. Levin BE, Dunn-Meynell AA, Balkan B, Keesey RE: Selective breeding for diet-induced obesity and resistance in Sprague-Dawley rats. Am J Physiol 1997;273:R725-R730.
10. Madsen AN, Hansen G, Paulsen SJ, Lykkegaard K, Tang-Christensen M, Hansen HS, Levin BE, Larsen PJ, Knudsen LB, Fosgerau K, Vrang N: Long-term characterization of the diet-induced obese and diet-resistant rat model: a polygenetic rat model mimicking the human obesity syndrome. J Endocrinol 2010;206:287-296.
11. Paulsen SJ, Jelsing J, Madsen AN, Hansen G, Lykkegaard K, Larsen LK, Larsen PJ, Levin BE, Vrang N: Characterization of beta-cell mass and insulin resistance in diet-induced obese and diet-resistant rats. Obesity (Silver Spring) 2010;18:266-273.
12. Li S, Zhang HY, Hu CC, Lawrence F, Gallagher KE, Surapaneni A, Estrem ST, Calley JN, Varga G, Dow ER, Chen Y: Assessment of diet-induced obese rats as an obesity model by comparative functional genomics. Obesity (Silver Spring) 2008;16:811-818.
13. Dobrian AD, Davies MJ, Prewitt RL, Lauterio TJ: Development of hypertension in a rat model of diet-induced obesity. Hypertension 2000;35:1009-1015.
14. Haddock RE, Grayson TH, Morris MJ, Howitt L, Chadha PS, Sandow SL: Diet-induced obesity impairs endothelium-derived hyperpolarization via altered potassium channel signaling mechanisms. PLoS One 2011;6: e16423.
15. Carroll JF, Zenebe WJ, Strange TB: Cardiovascular function in a rat model of diet-induced obesity. Hypertension 2006;48:65-72.
16. Halpern W, Mulvany MJ: Tension responses to small length changes of vascular smooth muscle cells (proceedings). J Physiol 1977; 265:21P-23P.
17. Mulvany MJ, Halpern W: Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 1977;41:19-26.
18. Takahashi K, Mizuarai S, Araki H, Mashiko S, Ishihara A, Kanatani A, Itadani H, Kotani H: Adiposity elevates plasma MCP-1 levels leading to the increased CD11b-positive monocytes in mice. J Biol Chem 2003;278: 46654-46660.
19. Kanda H, Tateya S, Tamori Y, Kotani K, Hiasa K, Kitazawa R, Kitazawa S, Miyachi H, Maeda S, Egashira K, Kasuga M: MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 2006;116: 1494-1505.
20. Mori MA, Liu M, Bezy O, Almind K, Shapiro H, Kasif S, Kahn CR: A systems biology approach identifies inflammatory abnormalities between mouse strains prior to development of metabolic disease. Diabetes 2010;59:2960-2971.
21. Hu E, Liang P, Spiegelman BM: AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 1996;271:10697-10703.
22. Yatagai T, Nagasaka S, Taniguchi A, Fukushima M, Nakamura T, Kuroe A, Nakai Y, Ishibashi S: Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type diabetes mellitus. Metabolism 2003;52: 1274-1278.
23. Basu R, Pajvani UB, Rizza RA, Scherer PE: Selective downregulation of the high molecular weight form of adiponectin in hyperinsulinemia and in type 2 diabetes: differential regulation from nondiabetic subjects. Diabetes 2007;56:2174-2177.
24. Hebbard LW, Garlatti M, Young LJ, Cardiff RD, Oshima RG, Ranscht B: T-cadherin supports angiogenesis and adiponectin association with the vasculature in a mouse mammary tumor model. Cancer Res 2008;68: 1407-1416.
25. Summer R, Little FF, Ouchi N, Takemura Y, Aprahamian T, Dwyer D, Fitzsimmons K, Suki B, Parameswaran H, Fine A, Walsh K: Alveolar macrophage activation and an emphysema-like phenotype in adiponectindeficient mice. Am J Physiol Lung Cell Mol Physiol 2008;294:L1035-L1042.
26. Shibata R, Sato K, Pimentel DR, Takemura Y, Kihara S, Ohashi K, Funahashi T, Ouchi N, Walsh K: Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK-and COX-2-dependent mechanisms. Nat Med 2005;11:1096-1103.
27. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE: The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 2001;7:947-953.
28. Pedersen BK, Febbraio MA: Muscle as an endocrine organ: focus on muscle-derived interleukin. Physiol Rev 2008;88:1379-1406.
29. Awazawa M, Ueki K, Inabe K, Yamauchi T, Kubota N, Kaneko K, Kobayashi M, Iwane A, Sasako T, Okazaki Y, Ohsugi M, Takamoto I, Yamashita S, Asahara H, Akira S, Kasuga M, Kadowaki T: Adiponectin enhances insulin sensitivity by increasing hepatic IRS-2 expression via a macrophage-derived IL-6-dependent pathway. Cell Metab 2011;13: 401-412.
30. Yuen DY, Dwyer RM, Matthews VB, Zhang L, Drew BG, Neill B, Kingwell BA, Clark MG, Rattigan S, Febbraio MA: Interleukin-6 attenuates insulin-mediated increases in endothelial cell signaling but augments skeletal muscle insulin action via differential effects on tumor necrosis factor-alpha expression. Diabetes 2009;58:1086-1095.
31. Sivitz WI, Wayson SM, Bayless ML, Sinkey CA, Haynes WG: Obesity impairs vascular relaxation in human subjects: hyperglycemia exaggerates adrenergic vasoconstriction arterial dysfunction in obesity and diabetes. J Diabetes Complications 2007;21:149-157.
32. Dobrian AD, Davies MJ, Prewitt RL, Lauterio TJ: Development of hypertension in a rat model of diet-induced obesity. Hypertension 2000;35:1009-1015.
33. Naderali EK, Brown MJ, Pickavance LC, Wilding JP, Doyle PJ, Williams G: Dietary obesity in the rat induces endothelial dysfunction without causing insulin resistance: a possible role for triacylglycerols. Clin Sci (Lond) 2001;101:499-506.
34. Vanhoutte PM: How we learned to say NO. Arterioscler Thromb Vasc Biol 2009;29: 1156-1160.
35. Vincent MA, Barrett EJ, Lindner JR, Clark MG, Rattigan S: Inhibiting NOS blocks microvascular recruitment and blunts muscle glucose uptake in response to insulin. Am J Physiol Endocrinol Metab 2003;285: E123-E129.
36. Chen H, Montagnani M, Funahashi T, Shimomura I, Quon MJ: Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem 2003;278:45021-45026.
37. Deng G, Long Y, Yu YR, Li MR: Adiponectin directly improves endothelial dysfunction in obese rats through the AMPK-eNOS pathway. Int J Obes (Lond) 2010;34:165-171.
38. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, Hotta K, Nishida M, Takahashi M, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y: Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999;100:2473-2476.
39. Davidson EP, Coppey LJ, Calcutt NA, Oltman CL, Yorek MA: Diet-induced obesity in Sprague-Dawley rats causes microvascular and neural dysfunction. Diabetes Metab Res Rev 2010;26:306-318.
40. Kim F, Pham M, Maloney E, Rizzo NO, Morton GJ, Wisse BE, Kirk EA, Chait A, Schwartz MW: Vascular inflammation, insulin resistance, and reduced nitric oxide production precede the onset of peripheral insulin resistance. Arterioscler Thromb Vasc Biol 2008;28:1982-1988.